Sign in
Taking people in South KoreaNo phase

Following People With Lymphoma Treated at Samsung Medical Center

Follows people with aggressive lymphoma, including Hodgkin and non-Hodgkin types, over time.

Key facts

Who runs it
Samsung Medical Center
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Status
Recruiting
People taking part
2,000 people, planned
Started
1 Jun 2022
Expected to end
30 Dec 2028
Type of study
Observational
Treatments tested
  • Immunochemotherapy
Record updated
13 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Hodgkin or non-Hodgkin lymphoma who need chemotherapy meant to remove all of the disease.

Age
20 years
Sex
All sexes can join.
Disease stage
Hodgkin or non-Hodgkin lymphoma, confirmed by pathology (tissue examination). The record describes aggressive lymphoma.

Main reasons for not taking part

  • Myeloid malignancy
  • Multiple myeloma
  • No need for chemotherapy meant to remove all of the disease

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Pathologically diagnosed Hodgkin and non-Hodgkin lymphomas
  • 20 years
  • Patients requiring systemic chemotherapy with curative intent
  • Written informed consent

Who cannot take part

  • Patients do not require systemic chemotherapy with curative intent
  • Myeloid malignancy
  • Multiple myeloma

Where in South Korea

  • Samsung Medical CenterSeoul, South KoreaContact: Seok Jin Kim, MD., PhD.Taking people

About the trial

What the trial wants to find out

This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum and cell-free DNA will be collected and analyzed.

Treatments tested

  • Immunochemotherapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective Study for Patients With Lymphoma at the Samsung Medical Center
Plain-language title
Following People With Lymphoma Treated at Samsung Medical CenterGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
13 October 2026